Dr. George Fehrenbacher, MD

Dr. Fehrenbacher practices at Sutter Roseville Medical Center in Roseville, California, part of Sutter Health.

Dr. Fehrenbacher's NPI, 1265404289, was assigned on February 3, 2006. Dr. Fehrenbacher graduated from UC Davis School of Medicine in 1982. Dr. Fehrenbacher holds California license G50702.

Dr. Fehrenbacher's primary practice is Sutter Roseville Medical Center, at One Medical Plaza, Roseville, CA 95661 in Placer County. The practice phone is (916) 781-1000. Dr. Fehrenbacher also practices at Sutter Roseville Medical Center, 1 Medical Plz, Roseville, CA 95661.

Dr. Fehrenbacher's primary practice is Sutter Roseville Medical Center in Roseville, California, part of Sutter Health. Dr. Fehrenbacher is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is Roseville Cardiology. Dmand AI also links Dr. Fehrenbacher to 3 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fehrenbacher practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Fehrenbacher's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Fehrenbacher is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Fehrenbacher's licenses on file in 2 states: California and Wisconsin.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and circulation problems among the conditions Dr. Fehrenbacher treats.

CMS data shows 3,292 Medicare services from Dr. Fehrenbacher across 29 procedure codes in 2024, for 1,068 Medicare patients. Medicare paid $345,848 for them.

CMS counts 1,068 Medicare patients who saw Dr. Fehrenbacher in 2024. The largest group is 75 to 84, with 441 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fehrenbacher's median patient age at 76, with 37% women.

In 2024, Dr. Fehrenbacher wrote 5,148 Medicare Part D claims for 644 patients. 88% of them were for generic drugs. CMS names the drug for 4,937 of them, across 42 drugs with 11 or more claims each, at $790,962 in total drug cost. In 2023, CMS named 5,079 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Fehrenbacher for performance year 2024, reported as part of a group. Dr. Fehrenbacher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 86 procedures of pacemaker insertion or repair by Dr. Fehrenbacher, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Fehrenbacher.

Dmand AI links Dr. Fehrenbacher to 1 clinical trial. Conditions studied include Coronary Artery Disease and Coronary Disease.

CMS Open Payments shows 455 general payments to Dr. Fehrenbacher from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 41% of the total. Abbott Laboratories paid the most, $9,627.

Dmand AI lists 2 awards for Dr. Fehrenbacher, most recently CMS Stage 1 EHR in 2013.

Dr. Fehrenbacher graduated from UC Davis School of Medicine in 1982. Dr. Fehrenbacher is a member of ACC.

Dr. Fehrenbacher is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.